Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD.

Gerardi, Daniel A; Gross, Nicholas J

Gerardi, Daniel A; Gross, Nicholas J.

Afiliación

Gerardi DA; Department of Pulmonary Medicine, Saint Francis Hospital and Medical Center, Hartford, Connecticut and The University of Connecticut School of Medicine, Farmington.
Gross NJ; University Medical Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut and The University of Connecticut School of Medicine, Farmington.

Chronic Obstr Pulm Dis ; 4(1): 1-3, 2017 Jan 05.

Article en En | MEDLINE | ID: mdl-28848905

Palabras clave

LABAs; chronic obstructive pulmonary disease; copd; long-acting beta2-agonists

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Chronic Obstr Pulm Dis Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google